Clinical Trials Browser

Phase 4 × enfortumab vedotin × 90 days × Clear all

NCT06862219 2026-05-28

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Phase 4 Recruiting

Carcinoma, Transitional Cell